Screener
BridgeBio Pharma BBIO Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on the most recent quarter.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's current ratio?
- BridgeBio Pharma (BBIO) reported current ratio of 1.5× in Q1 2026.
- How has BridgeBio Pharma's current ratio changed year-over-year?
- BridgeBio Pharma's current ratio decreased by 66.7% year-over-year, from 4.6× to 1.5×.
- What is the long-term trend for BridgeBio Pharma's current ratio?
- Over 5 years (2020 to 2025), BridgeBio Pharma's current ratio has grown at a -16.2% compound annual growth rate (CAGR), from 6.7× to 2.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about BridgeBio Pharma's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude